CD4 and myeloid sarcoma: The reduced number of IFN-γ–secreting cells, which was observed in the ELISpot analyses, could also be caused by a reduction of the Th1 fraction within the CD4+ lymphocyte pool, which was already seen in MS patients (20, 21).